Biosimilar battles; key developments in the UPC; IBM interview; Huawei smart meter agreement; Korean NPE ambitions; more… – IAM

0

Everything we’ve covered on IAM over the past seven days – and everything you need to know about the global intellectual property market to prepare for the start of another busy week.

MONDAY APRIL 8

A guide to the ongoing biosimilar battles as Johnson & Johnson reaches Stelara settlement

Diving into data: Patent cases tangled in a dispute between lawyer and litigation funder

TUESDAY APRIL 9

The main developments of the Unified Patent Court in the first quarter of 2024

Interview: Charles Varvaro, intellectual property leader at IBM, reaches the one-year milestone

Chinese companies risk being overtaken on patents in sustainable areas

WEDNESDAY APRIL 10

Trade secrets: India begins first steps in overhauling trade secret protection

Long read: It was the perfect time to buy patents in 2023

Opponents and supporters of US patent eligibility reform lobby Congress

THURSDAY, 11TH OF APRIL

Huawei enters into licensing agreement with major smart meter supplier

Landmark UPC appeal ruling has mixed transparency implications

House committee calls for rescinding USPTO AI inventory guidance

FRIDAY APRIL 12TH

Interview: Using Trade Secret Strategy to Lead an Unmanned Software Business to Success

Korean NPE Intellectual Discovery seeks to become third major player in intellectual property monetization

Global dispute over UK FRAND rates settled at last minute

SATURDAY APRIL 13

Notice: Navigating the Intellectual Property Maze in the Age of AI Newscasters

T
WRITTEN BY

Related posts